 LOS ANGELES, June 28, 2021 PRNewswire -- ImmunoCellular Therapeutics, Ltd. ImmunoCellular OTC: IMUC, today announced that the Company has taken steps to comply with amended Rule 15c2-11 under the Securities and Exchange Act which will be applicable in September 2021. 